| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0190-9622(95)90239-2 |
| P698 | PubMed publication ID | 7622649 |
| P2093 | author name string | Pouteil-Noble C | |
| Touraine JL | |||
| Euvrard S | |||
| Kanitakis J | |||
| Thivolet J | |||
| Dureau G | |||
| Claudy A | |||
| Faure M | |||
| P433 | issue | 2 Pt 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 222-229 | |
| P577 | publication date | 1995-08-01 | |
| P1433 | published in | Journal of the American Academy of Dermatology | Q15757046 |
| P1476 | title | Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation | |
| P478 | volume | 33 |
| Q42505721 | 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography illustrates two visceral tumors in a post kidney transplant patient with multiple cutaneous malignancies |
| Q44216189 | Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation |
| Q36883501 | Actinic keratoses. Differential diagnosis and treatment |
| Q33785049 | Actinic keratosis: rationale and management |
| Q71260094 | Atypical fibroxanthoma in a renal graft recipient |
| Q36161595 | Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature |
| Q35541129 | Bowenoid papulosis of the vulva—immunotherapeutical approach with topical imiquimod |
| Q33495757 | Cancer incidence in kidney transplant recipients: a study protocol |
| Q42479423 | Capecitabine for skin cancer prevention in solid organ transplant recipients |
| Q45083617 | Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients. |
| Q79292852 | Cutaneous precancers in organ transplant recipients: an old enemy in a new surrounding |
| Q36390995 | Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification. Part one. |
| Q91362027 | De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data |
| Q48179572 | Decision tree analysis to stratify risk of de novo non-melanoma skin cancer following liver transplantation. |
| Q47572587 | Dermatological Complications After Solid Organ Transplantation |
| Q37779991 | Dermatopathology of skin cancer in solid organ transplant recipients |
| Q42521744 | Differential expression of stromal MMP-1, MMP-9 and TIMP-1 in basal cell carcinomas of immunosuppressed patients and controls |
| Q35017520 | Efficacy of photodynamic therapy for treatment of basal cell carcinoma in organ transplant recipients |
| Q92368463 | Epidermolysis bullosa: Advances in research and treatment |
| Q80381252 | Evaluation of posttransplantation malignancies compared with de novo tumors |
| Q42460507 | First and subsequent nonmelanoma skin cancers: incidence and predictors in a population of New Zealand renal transplant recipients |
| Q41561185 | HPV infections and immunosuppression |
| Q42501628 | High rejection score in the first year and risk of skin cancer in heart transplantation. |
| Q41467144 | Human papillomavirus-associated tumors of the skin and mucosa |
| Q36830121 | Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review |
| Q42478812 | Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. |
| Q33918427 | Incidence of and risk factors for skin cancer after heart transplant |
| Q45247488 | Long-term voriconazole and skin cancer: is there cause for concern? |
| Q37782262 | Malignancy after renal transplantation: the role of immunosuppression |
| Q34784781 | Malignancy in organ transplantation: heart |
| Q36158929 | Molecular aetiology and pathogenesis of basal cell carcinoma |
| Q38228585 | Optimal management of skin cancer in immunosuppressed patients |
| Q53375814 | P16 and p53 expression in (pre)malignant epidermal tumors of renal transplant recipients and immunocompetent individuals. |
| Q37965984 | Photodynamic therapy for actinic keratosis in organ transplant patients. |
| Q77325519 | Posttransplantation skin cancer: scope of the problem, management, and role for systemic retinoid chemoprevention |
| Q41033568 | Premalignant keratinocytic neoplasms |
| Q42526547 | Risk factors associated with the development of skin cancer after liver transplantation |
| Q82948889 | Risk of non-melanoma skin cancer in autoimmune hepatitis |
| Q33683977 | Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus |
| Q37432717 | Skin cancer after transplantation |
| Q42467117 | Skin cancer in Australian heart transplant recipients |
| Q63369190 | Skin cancer in heart transplant recipients: frequency and risk factor analysis |
| Q74455780 | Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens |
| Q34355645 | Skin cancer in the elderly |
| Q35128119 | Skin cancers after transplantation |
| Q42493820 | Skin lesions in adult liver transplant recipients: a study of 100 consecutive patients |
| Q42515657 | Skin tumours in the West of Scotland renal transplant population |
| Q42437448 | Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre |
| Q34587546 | Squamous cell carcinoma of the head and neck in solid organ transplant recipients |
| Q37124260 | Study of dermatoses in kidney transplant patients |
| Q41679985 | Study of factors affecting the incidence of skin cancer in patients after liver transplant |
| Q42445526 | The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies |
| Q49060314 | The haptoglobin phenotype influences the risk of cutaneous squamous cell carcinoma in kidney transplant patients |
| Q42096015 | The incidence and risk factors of de novo skin cancer in the liver transplant recipients |
| Q36103139 | The relative effects of different systemic immunosuppressives on skin cancer development in organ transplant patients |
| Q42439568 | The therapy of virus-associated epithelial tumors of the face and the lips in organ transplant recipients |
| Q34728470 | Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer |
| Q44654963 | Treatment of Bowen's disease and erythroplasia of Queyrat |
| Q41481044 | Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. |
| Q36103147 | Use of topical immunomodulators in organ transplant recipients |
| Q72993215 | [Dermatologic complications after heart transplantation: incidence and prognosis] |
| Q73829667 | [Skin cancer in patients submitted to organ transplantation: a growing problem] |
Search more.